Abstract-Rett syndrome (RTT) is associated with mutations
Rett syndrome (RTT) is a progressive neurodevelopmental disorder in females caused by loss-of-function mutations in the X-linked MeCP2 gene (Amir et al., 1999) . RTT is characterized by arrested neurological development and subsequent cognitive decline, motor impairments and frequent seizures (Hagberg et al., 1983; Naidu, 1997) . Examination of the RTT brain reveals profound microencephaly due, at least in part, to smaller and more densely packed neurons. Other abnormalities include a reduction in dendritic arborization (Kriaucionis and Bird, 2003; Zoghbi, 2003) . Several studies have shown that MeCP2 is abundantly expressed within the CNS almost exclusively in neurons where its expression is highly enriched in postmitotic neuronal nuclei (Akbarian et al., 2001; Jung et al., 2003; Mullaney et al., 2004) . However, recent reports have also localized MeCP2 outside of the nucleus (Mnatzakanian et al., 2004) and in the post-synaptic compartment (Aber et al., 2003) , suggesting that MeCP2 may have a role outside of the nucleus including synaptic function (Aber et al., 2003; Nelson et al., 2006) . However, there is little understanding of the extranuclear function of MeCP2 in the CNS.
The MeCP2 gene encodes a protein called the methylCpG binding protein 2 (MeCP2), a member of the methylbinding protein (MBD) family, which is a key factor in epigenetic transcriptional regulation. MeCP2 functions as a transcriptional repressor that specifically binds to methylated "CpG" dinucleotides preferentially located in the promoter region of genes regulated by methylation (Lewis et al., 1992) . Once bound to methylated DNA, MeCP2 is reported to suppress downstream gene expression by virtue of its interaction with histone deacetylase/Sin3 complex (Nan et al., 1997; Jones et al., 1998) . Although biochemical evidence is consistent with MeCP2 functioning as a transcriptional repressor (Nan et al., 1997) , many recent studies have failed to detect significant gene derepression in MeCP2 mutant mouse (Tudor et al., 2002) . The strong expression of MeCP2 in mature neurons and the neuronal phenotype of RTT patients raised the possibility that MeCP2 may be involved as a selective regulator of, as yet unknown, neuronal functions.
The synaptic neurotransmitter abnormalities reported in RTT appear to be associated with high levels of glutamate neurotransmission and higher densities of N-methyl-D-aspartate (NMDA) and AMPA receptors in younger females, suggesting an enhanced excitatory glutamatergic function in the CNS of younger RTT subjects (Lappalainen et al., 1996; Blue et al., 1999) . Several reports have indicated that NMDA receptor activation is required for synaptic pruning and that blocking of NMDA receptors prevents this process (Rabacchi et al., 1992; Luthi et al., 2001) . Furthermore, the excitatory neurotransmitter glutamate, which has a trophic effect in the developing brain (McDonald and Johnston, 1990; Johnston, 2001; Johnston et al., 2001) , can induce neurotoxicity and cell death following prolonged and excessive activation of NMDA and AMPA subtypes of glutamate receptors (Choi, 1988) . Previously, we found that in vitro exposure of primary cerebellar granule neurons to NMDA caused significant neuronal death and the growth and neurotrophic factor fibroblast growth factor 1 (FGF-1) protected against NMDA-induced excitotoxicity and death (Hossain et al., 2002) . In the present study, we investigated the effects of insufficient expression of the transcriptional repressor MeCP2 on neuronal functions specific to injury and survival in cultured primary cerebellar granule neurons isolated from postnatal day 6 (P6) old wild type (WT) and MeCP2 knockout mouse brain. The cerebellum is an important area of interest both clinically and anatomically because of its involvement in motor functions, its prolonged period of postnatal development and delayed expression of MeCP2 in granule cells relative to that in Purkinje cells (Naidu et al., 2003; Mullaney et al., 2004) . Furthermore, the cerebellum appears to be preferentially affected in RTT from the standpoint of both neuropathology and clinical signs of tremor and ataxia (Oldfors et al., 1990; Murakami et al., 1992) . Here, we examined whether MeCP2 deficiency (i ) directly contributes to the neuronal response to injury/death mechanism triggered by exposure to excitotoxicity and hypoxia, and (ii ) alters the response to neuroprotection by growth and neurotrophic factors.
EXPERIMENTAL PROCEDURES Cerebellar granule neuronal cultures
The Johns Hopkins University Institutional Animal Care and Use Committee approved all animal protocols used; they complied with the US NIH guide for the Care and Use of Laboratory Animals. All efforts were made to minimize the number of animals used and any pain or suffering. Mecp2 tm1.1Bird mice (Jackson Laboratory, Bar Harbor, ME, USA) on a C57BL/6 background (heterozygote backcrossed with C57BL/6 males for at least nine generations) were used for all experimental procedures (Metcalf et al., 2006) . The MeCP2 null mouse used in this study provides an excellent animal model for human RTT with the potential for understanding its molecular mechanisms (Guy et al., 2001; Kriaucionis and Bird, 2003) . Primary cultures of cerebellar granule cells (CGC) were prepared from P6 old WT and MeCP2 null mice cerebella according to methods described previously (Hossain et al., 2002) . Cells were resuspended in a K25ϩS medium consisting of 10% FBS (Gemini Bioproducts, Calabasas, CA, USA), 25 mM KCl, gentamycin (50 g/ml) and L-glutamine (2 mM) in Basal Medium Eagle (Life Technologies, Inc., Rockville, MD, USA) and were seeded at a density of 2.5ϫ10 5 cells/cm 2 area in multi-well plates or in dishes (Corning, Inc., Corning, NY, USA) precoated with poly-Llysine (100 g/ml; Sigma, St. Louis, MO, USA). The cells were maintained at 37°C in the presence of 5% CO 2 /95% air in a humidified incubator. Cytosine arabinofuranoside (AraC, 5 M; Sigma) was added to cultures 24 h after plating to arrest the growth of non-neuronal cells. With this protocol, 95-99% of the cultured cells were granule neurons (Dudek et al., 1997; Li et al., 2000; Hossain et al., 2002) . The cells were used for experiments after 10 days in vitro (DIV 10).
Induction of excitotoxicity and hypoxia
Experiments were conducted at DIV 10, when cultures consisted primarily of neurons (Ͼ95% MAP-2 immunoreactive cells) (MAP-2; Chemicon, Temecula, CA, USA). At least 2 h before excitotoxicity or hypoxia was induced, the K25ϩS medium for the CGCs was replaced with a serum-free medium containing 25 mM KCl (K25-S) (Hossain et al., 2002) . Serum-free medium was used in all experiments to isolate the survival-promoting effect of FGF-1 alone, since in granule cells, serum provides a survival-promoting activity of unknown origin (Timothy and Johnson, 1996) . The KCl (25 mM) was included in the medium (K25ϩS) to ensure normal neuronal development and survival in culture (D'Mello et al., 1993) and to minimize neuronal death from causes other than excitotoxicity.
Neurotoxicity was induced by adding NMDA (0 -500 M) or AMPA (0 -150 M) directly to the K25-S medium; and CGCs were incubated for ϳ20 h at 37°C in a humidified incubator (5% CO 2 /95% air). Immediately after the period of exposure, cell toxicity was measured in the CGCs.
Hypoxia was induced by exposing cells to humidified 95% N 2 /5% CO 2 at 37°C using a modular incubator chambers (BillupsRothenberg, Del Mar, CA, USA) for various time periods (0 -16 h) as described previously (Hossain et al., 2004a) . Control cultures were exposed to humidified 95% air/5% CO 2 at 37°C for the same duration. Subsets of parallel cultures were pretreated with human recombinant FGF-1 (40 ng/ml; Sigma) for 2 h before exposure to hypoxia (10 h). Cells were placed in a serum-free medium containing 25 mM KCl (K25-S) 2 h before exposure to hypoxia. Control cultures were also in K25-S medium and received an equal volume of BSA (0.1 mg/ml), which had no detectable responses on cell survival or in the biochemical assays (Dudek et al., 1997) .
Assessment of cell viability/toxicity. Immediately after the period of exposure to excitotoxicity or hypoxia, cell viability and/or death was determined by independent and complementary methods. (4, assay. Mitochondrial dehydrogenase activity cleaves MTT (Sigma) and is a biochemical index for cellular viability. A quantitative colorimetric assay of MTT (Nonaka et al., 1998) used to determine cell survival. The tetrazolium ring of MTT is cleaved by various dehydrogenase enzymes in active mitochondria, forming a blue-colored insoluble product, formazan. CGCs were incubated with MTT (125 g/ml) added to the growth medium for 1 h at 37°C. The medium was then aspirated and the formazan product was dissolved in 500 ml dimethylsulfoxide and quantified spectrophotometrically at 540 nm using a Spectra MAX 340pc plate reader (Molecular Devices, Sunnyvale, CA, USA) as described previously (Hossain et al., 2002 (Hossain et al., , 2004a . The results were expressed as a percentage of control culture viability.
3-
Lactate dehydrogenase (LDH) assay. LDH activity released in the media after hypoxic exposure was measured using the CytoTox96 Non-radioactive Cytotoxicity Assay kit (Promega, Madison, WI, USA) as described previously (Hossain et al., 2004a) . Percent cell death was determined using the formula: % cytotoxicityϭhypoxic LDH release (OD 490 )/maximum LDH release (OD 490 ) after correcting for baseline absorbance of LDH release at 490 nm.
Terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) staining. The DeadEnd Fluorometric TUNEL System (Promega) was used to detect cell death in cultured cerebellar granule neurons exposed to hypoxia (10 -12 h) as described previously (Hossain et al., 2004a) . Fluorescence was visualized in a fluorescence microscope (Carl Zeiss Axioplan 1) with an excitation at 485 nm and an emission at 535 nm. 4,6-Diamino-2-phenylindole (DAPI) fluorescence (blue) was visualized with an excitation and emission filters at 365 nm and 450 nm, respectively.
Immunofluorescence
Double immunofluorescence staining of primary CGC cultures (grown on coverslips) was conducted using primary antibodies specific for MeCP2 (Upstate, Lake Placid, NY, USA; rabbit polyclonal) and SNAP25, a neuron specific marker (kindly supplied by Dr. Jonathan Pevsner, Kennedy Krieger Institute, Baltimore, MD, USA) to determine MeCP2 protein expression in neuronal cells. CGCs at DIV 10 were fixed with 3.7% formaldehyde and permeabilized cells were incubated with MeCP2 (1:200) and SNAP25 (1:250) antibodies overnight at 4°C according to our previously described method (Hossain et al., 2004b) . For negative controls appropriate non-immune IgG was used instead of primary antibodies. Cells were washed and stained with multiple fluorochrome-conjugated secondary antibodies (Texas Red-conjugated goat anti-mouse for MeCP2; red, and FITC-conjugated goat anti-rabbit for SNAP-25; green) and DAPI (blue) that stain nuclei for 1 h at RT. DAPI stains all cell nuclei with blue fluorescence regardless of viability. Slides were coverslipped with Prolong mounting medium (Molecular Probes, Eugene, OR, USA). MeCP2-and SNAP25-specific immunofluorescence was visualized using a fluorescence microscope (Carl Zeiss Axioplan 1 microscope fitted with AxioVision 3.0 software) at 100ϫ magnification.
Subcellular fractionation
Subcellular fractionation was performed as described by Shou et al. (2002) . Briefly, cells were harvested in ice cold PBS and centrifuged at 3600ϫg for 5 min. Cell pellets were resuspended in isotonic mitochondrial buffer (MB) consisting of 210 mM mannitol, 70 mM sucrose, 1 mM EDTA and 10 mM Hepes, pH 7.5, supplemented with protease and phosphatase inhibitor cocktails (Calbiochem, San Diego, CA, USA). Cells were homogenized with a Dounce homogenizer for 50 strokes and were centrifuged at 500ϫg for 5 min. The resulting supernatant was centrifuged further at 10,000ϫg for 30 min at 4°C. The pellet contained the mitochondrial fraction and was suspended in 100 l MB buffer containing 0.1% Triton X-100 to break up the mitochondria; the supernatant was used as the cytosolic fraction.
Transient transfection
Primary cerebellar granule neurons were isolated from mice cerebella and transfected by nucleofection system using Rat Neuron Nucleofector kit (Amaxa, Inc., cat. No. VPG-1003) according to the manufacturer's instructions (Krauss et al., 2003) . Isolated primary cells in suspension containing 12ϫ10 6 cells were mixed with 2 g of plasmid DNA for nucleofection and seeded at a density of 2.5ϫ10 5 cells per cm 2 area in different cell cultures plates depending on the nature of experiments. Using this technique, we achieved Ͼ65% transfection efficiencies in primary CGC cultures as determined by green fluorescent protein (GFP) expression.
Commercially available control siRNA (Santa Cruz, cat. No. sc-37007) and MeCP2 siRNA (Santa Cruz, was transfected into cells using LipofectAMINE RNAiMAx (Invitrogen, Carlsbad, CA, USA) according to manufacturer's instructions. Briefly, cells were grown on coverslips in 12-well plates at a density of 2.5ϫ10 5 /cm 2 area and placed in fresh medium without antibiotic. Control scramble siRNA or MeCP2 siRNA (0.3-0.4 nmol) per well and Lipofectamine TM RNAiMAX complex was prepared in a total volume of 100 l according to manufacturer's instruction. One hundred microliters of the siRNA-lipofectamine RNAiMAX complex was then added to each well and cells were incubated at 37°C in a 5% CO 2 cell culture incubator for 5 h. The transfection medium was then aspirated; cells were washed with fresh transfection medium, and then replenished with previously saved conditioned medium (Li et al., 2000) . Experimental treatments were initiated ϳ48 h after transfection. With this protocol, we have achieved Ͼ80% reduction in MeCP2 protein levels compared with control siRNA as determined by Western blot and immunofluorescence analyses.
SDS-PAGE and Western blot analyses
SDS-PAGE and immunoblotting were performed according to the method of Laemmli (1970) with modifications as described previously (Hossain et al., 2002) . Briefly, CGC extracts were prepared using 100 l of ice-cold lysis buffer RIPA (PBS 1ϫ, 1% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS) containing 1ϫ protease cocktail inhibitor set 1 (Calbiochem, #539131), sodium vanadate (1 mM), sodium pyrophosphate (2 mM) and sodium ␤-glycerophosphate (1 mM) and stored at Ϫ70°C. Protein concentrations were determined using the Coomasie protein assay (Pierce, Rockford, IL, USA) according to the manufacturer's instructions.
Total proteins (10 -20 g) were diluted in Laemmli buffer containing ␤-mercaptoethanol, heated to 100°C for 5 min, separated on a 4 -20% gradient Tris-glycine pre-cast gel (Invitrogen) at 140 V for 1 h, and then immunoblotted with specific primary antibody to MeCP2 (1:500; Upstate), total and cleaved caspase-3 and -9 (1:500; Cell Signaling, Beverly, MA, USA), AIF (1:500; Santa Cruz Biotechnology) and actin (1:1000). Horseradish peroxidase (HRP)-conjugated secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, PA, USA) were used at 1:1000 dilutions for 1 h at RT. HRP reaction product was then visualized by enhanced chemiluminescence using an ECL Western blotting detection kit (Amersham-Pharmacia). Digitized images were quantified by densitometry (Molecular Dynamics).
Statistical analysis
Statistics were performed using StatView 5.0 program. Comparisons involving multiple groups were done by ANOVA, followed by Bonferroni/Dunn post hoc tests where appropriate.
RESULTS

MeCP2 expression in cerebral granule neuronal cultures
To elucidate the effects of MeCP2 deficiency in neuronal response to injury and death, we first examined MeCP2 protein expression in a well-characterized culture system of primary cerebellar granule neurons. Dissociated primary neuronal cultures allow examination of specific neuronal function independent of potential general alterations in brain homeostasis, thereby enabling a distinction between cell-autonomous defects and global systemic dysfunction. Immunofluorescence analysis of MeCP2 expression using a MeCP2-specific antibody showed intense MeCP2-specific immunofluorescence (red) in the nuclear region of WT neurons (Fig. 1A) . In contrast, MeCP2 Ϫ/Ϫ CGCs showed complete absence of MeCP2 proteins (Fig. 1C) . Double immunofluorescence staining with MeCP2 and SNAP25, a specific neuronal marker, revealed MeCP2 expression exclusively in neurons (Fig. 1B) . No MeCP2-and SNAP25-specific immunofluorescence was observed in cultures incubated with nonimmune IgG (negative controls, Fig. 1E,  1F) . We found MeCP2 colocalized with DAPI, a dye that binds nucleic acid and stain nuclei, in SNAP25 positive cells (Fig. 1B) . These results indicated that all MeCP2 positive cells were neurons and that MeCP2 staining was within the nucleus.
Effects of NMDA-and AMPA-induced excitotoxicity in MeCP2؊/؊ cerebellar granule cultures
To determine whether MeCP2 deficiency contributes to neuronal pathogenesis, we exposed primary CGC cultures isolated from MeCP2 null and WT mouse brains to excitotoxic or hypoxic conditions. Primary CGC cultures (DIV 10) were exposed to NMDA (0 -500 M) (Fig. 2A) or AMPA (0 -150 M) (Fig. 2B) for ϳ20 h. Quantification of cell viability by MTT assay revealed that 200 M of NMDA and 100 M of AMPA resulted in ϳ40 -50% cell death (PϽ0.01) compared with respective littermate controls. At each concentration of NMDA or AMPA, percent cell death was significantly higher in MeCP2Ϫ/Ϫ granule neurons (PϽ0.01) compared with that in WT cultures (Fig. 2) . Since in RTT, girls are heterozygous for the MeCP2 gene, we also examined excitotoxicity in CGC cultures from heterozygous (ϩ/Ϫ) mice. Exposure of heterozygous (ϩ/Ϫ) CGC cultures to NMDA and AMPA (not shown) showed a similar pattern of cell death (Fig. 2C) to that from MeCP2Ϫ/Ϫ cultures ( Fig. 2A and 2B) . Thus, the percentage of NMDA and AMPA-induced neuronal death in MeCP2 protein deficient or absent cells is increased relative to that in WT littermate cerebellar granule neurons.
Hypoxia-induced cell death in MeCP2؊/؊ cerebellar granule neurons
Since glutamate receptor-mediated excitotoxicity is a major contributor to neuronal death in hypoxic-ischemic brain injury (Johnston, 2001) , we next examined whether MeCP2 deficiency altered the neuronal response to hypoxia-induced cell death. Hypoxia (0 -16 h) was induced in DIV 10 cultured cells. MTT quantification showed a significantly lower cell viability (50%; PϽ0.01) occurring in MeCP2Ϫ/Ϫ granule cells after 8 h of hypoxia than that observed in WT cells (ϳ75%) under identical conditions (Fig. 3A) . These results indicate that WT and MeCP2Ϫ/Ϫ CGC cultures have a differential sensitivity to hypoxiainduced cell death. Our results also revealed that the onset of significant neuronal death in MECP2Ϫ/Ϫ cells occurred earlier (5 h) than in the WT cultures (PϽ0.01) (Fig. 3A) . Pretreatment of CGC cultures with FGF-1 (40 ng/ml) was neuroprotective (PϽ0.01) against hypoxia (10 h) -induced death both in MeCP2Ϫ/Ϫ and WT neurons (Fig. 3B) . However, the magnitude of FGF-1-mediated neuroprotection was less in MeCP2 null cells (PϽ0.05) than in the WT (Fig. 3B) . Collectively, the results demonstrate that MeCP2 deficiency in cerebellar granule neurons produced a higher degree of cell death when MeCP2Ϫ/Ϫ neurons were exposed to excitotoxicity or hypoxia, and that MeCP2 deficiency altered the neuronal response to the FGF-1-mediated neuroprotection against cell death.
MeCP2 deficiency in neurons enhances proapoptotic death pathways
Mitochondria release proteins that propagate both caspase-dependent and caspase-independent cell death pathways. Caspase-3 is a terminator protein that triggers the execution phase of apoptosis. We performed a Western blot analysis of total cellular extracts from WT and MeCP2Ϫ/Ϫ cells (DIV 10 cultures) under normoxia or after 6 h exposure to hypoxia. Densitometric quantification of cleaved caspase-3 specific immunoreactive protein bands (ϳ17 kDa; normalized to actin) revealed a twofold increase in the MeCP2Ϫ/Ϫ cells, (PϽ0.01) in levels of activated caspase-3 after 6 h of hypoxia, compared with WT and knockout (KO) normoxia controls and WT hypoxia controls (100%) (Fig. 4) . This result suggests that the greater magnitude of cell death in MeCP2Ϫ/Ϫ cells is due the enhanced activation of caspase-3 proteins.
We next determined whether caspase-independent pathways also contribute to the increased cell death in MeCP2Ϫ/Ϫ neurons after hypoxia, by examining the role of apoptosis inducing factor (AIF), a caspase-independent death regulator. Cell fractionation experiments isolated mitochondrial and cytoplasmic fractions, which were then examined by Western blot analysis. AIF was released and translocated to the cytoplasm in response to hypoxia. Under normoxia conditions, AIF-specific intense immunoreactive protein band was detected (67 kDa) in the mitochondrial fraction from both WT and MeCP2Ϫ/Ϫ cells (Fig. 5A) . After exposure to hypoxia for 6 h, mitochondrial AIF release increased in MeCP2Ϫ/Ϫ cells. Evidence for this release was the concurrent decrease in AIF protein levels (Ͼ50%; PϽ0.01) in the mitochondrial fraction (normalized to mitochondrial specific marker prohibitin) along with the simultaneous increase of AIF in the cytoplasmic fraction (PϽ0.01) (Fig. 5A) . AIF levels in mitochondrial and cytosolic fractions of WT cells did not change after exposure to hypoxia (Fig. 5A) . The results suggest that increases in AIF release may contribute to the enhanced cell death observed in MeCP2Ϫ/Ϫ cerebral granule cells after hypoxia. Thus, both caspase-and AIF-dependent cell death pathways contributed to enhanced cell death after hypoxia in MeCP2Ϫ/Ϫ cells.
To more specifically determine whether hypoxia-induced AIF release occurs via a caspase-dependent or independent manner, we pretreated WT and MeCP2Ϫ/Ϫ cells with the general caspase inhibitor ZVAD-FMK (100 M) (BD Pharmingen) 1 h before exposure to hypoxia (6 h). Cells were double immunostained with AIF (Santa Cruz) and mitochondrial specific marker ATP synthase (Chemicon) and coverslipped with mounting medium that contained DAPI, a dye that binds and stains the nucleus (Fig. 5B) . Overlapping digitized images of mitochondrial proteins AIF (red) and ATP synthase (green) staining showed overlapping images (yellow), which were completely absent in the nucleus (blue) ( Fig. 5B; upper panels) . In contrast, after 6 h of hypoxia, the majority of the AIFspecific immunofluorescence (red) was localized in the cytoplasm and nucleus (purple) of MeCP2Ϫ/Ϫ cells (bottom panels) compared with mitochondrial localization in the WT cells. Pretreatment with the caspase inhibitor ZVAD-FMK had no effects or only marginally reduced the magnitude of AIF translocation to the cytoplasm and nucleus in MeCP2Ϫ/Ϫ cells (Fig. 5B) . Our results suggest that AIF release from mitochondria in the MeCP2Ϫ/Ϫ cells after hypoxia occurred via a caspaseindependent pathway.
Specificity of MeCP2 deficiency in cell death mechanism
To examine the mechanistic role of MeCP2 deficiency in the cell death response, we used a strategy of overexpressing the intact MeCP2 gene in MeCP2 null CGCs. MeCP2Ϫ/Ϫ and WT cells were transfected with control plasmid DNA or the pTAU-MeCP2pAneo expression vector DNA (kindly provided by Dr. Rudolf Jaenisch) (Luikenhuis et al., 2004) as described and 48 h later exposed to hypoxia (8 h). Hypoxia-induced neuronal death was assessed independently by LDH release and MTT cell viability assays. Hypoxia exposure caused Ͼ50% cell death in MeCP2Ϫ/Ϫ cells compared with WT cells (Fig. 6) . However, reintroduction of MeCP2 gene into null cells significantly reduced cell death (PϽ0.001) after hypoxia (Fig. 6) .
We next used TUNEL staining in the CGC cultures as an independent complementary method for examining neuronal death in MeCP2Ϫ/Ϫ cells (Fig. 7) . Intense TUNEL (ϩ) cells were detected both in the WT and MeCP2Ϫ/Ϫcultures after 8 h of hypoxia compared with respective normoxia controls. However, the number of TUNEL (ϩ)-cells was significantly higher (ϳfivefold; PϽ0.01) in MeCP2Ϫ/Ϫ cultures than that in the MeCP2 WT cells under identical conditions (Fig. 7A) . Overexpression of MeCP2 in MeCP2 null neurons led to a significant decrease in the number of TUNEL (ϩ) cells compared with untransfected null neurons (Fig. 7B) . Next, we used MeCP2 gene silencing strategy in WT CGC cultures using MeCP2 siRNA (Santa Cruz) to examine the functional requirement of MeCP2 for the observed effects. WT CGCs at DIV 8 were transfected with MeCP2 siRNA or control siRNA as indicated and 48 h after transfection were exposed to 8 h hypoxia (Fig. 7C) . TUNEL staining and quantification of TUNEL (ϩ) cells revealed a significant increase in cell death (PϽ0.01) in MeCP2siRNA-transfected cells after exposure to hypoxia relative to control siRNA-transfected cells (Fig. 7C) . These results together demonstrate a direct role of MeCP2 in neuronal death/survival mechanism, and that insufficient expression of MeCP2 is directly involved in the greater magnitude of cell death in MeCP2Ϫ/Ϫ CGCs.
DISCUSSION
The present study provides the first evidence that the loss of functional MeCP2 expression in central neurons leads to greater cell injury/death after exposure to different pathological conditions such as excitotoxicity and hypoxic-ischemic insults. We also found shorter durations of exposure, which caused no or relatively little cell death in WT neurons, led to significant cell death in MeCP2Ϫ/Ϫ CGC cultures. Particularly interesting was the finding that CGC cultures from MeCP2 heterozygous mice also showed cell death with a magnitude comparable to that in MeCP2 null cells. The specific action of the MeCP2 deficit on the cell death mechanism was further demonstrated by MeCP2 gain/loss-of-function strategies using MeCP2Ϫ/Ϫ and WT cells. After hypoxia, activation of the proapoptotic death effector caspase-3 was enhanced and AIF release from the mitochondria and translocation to the nucleus was increased in MeCP2Ϫ/Ϫ cells. Furthermore, the caspase-3 activation and increased AIF release was observed at a shorter duration of exposure in MeCP2Ϫ/Ϫ cells compared with that in WT cells. Our findings suggest that these proapoptotic death cascade pathways could account for the enhanced cell death observed in MeCP2Ϫ/Ϫ cerebellar granule neurons.
Modeling RTT in primary neuronal cultures
The cerebellum is an important area of interest for RTT research; it is an area with distinct changes in neuropathology and cerebellar deficits may underlie the clinical signs of tremor and ataxia (Oldfors et al., 1990; Murakami et al., 1992; Naidu et al., 2003) . In the present study, we used well-characterized primary neuronal cultures of cerebellar granule neurons obtained from MeCP2 null mice cerebella as an in vitro RTT model. Primary neuronal cultures provide an excellent model for investigating the molecular and intracellular signaling events that regulate neuronal death and survival. The high degree of cellular homogeneity (D'Mello et al., 1993; Dudek et al., 1997) of primary neuronal cultures, the predictable expression of a neuronal phenotype in vitro, including an extensive neuritic network and the expression of multiple glutamate receptor subtypes (Cox et al., 1990) , make it possible to distinguish between cell-autonomous defects and global systemic dysfunction. We examined the effects of MeCP2 loss on cell death mechanisms in this model of cultured CGCs to determine whether MeCP2 deficiency in central neurons contributes to neuronal pathogenesis observed in RTT.
The MeCP2 null mouse used for this study is an established animal model of human RTT (Guy et al., 2001; Kriaucionis and Bird, 2003) . Studies using MeCP2 null and heterozygous mice suggest that MeCP2 heterozygous females, which are genetically most comparable to human RTT patients display symptoms similar to MeCP2 null mice but at an older age (Guy et al., 2001; Kriaucionis and Bird, 2003) . We observed that MeCP2 deficiency in cerebellar granule neurons leads to a greater degree of cell death when MeCP2Ϫ/Ϫ neurons were exposed to excitotoxicity and hypoxic conditions. We also found that cerebellar granule neurons from MeCP2 (ϩ/Ϫ) heterozygous females were more sensitive to NMDA-mediated excitotoxicity than cells from MeCP2 WT mice.
The role of MeCP2 in enhanced cell death
The NMDA and AMPA subtypes of glutamate receptors play a critical role in mediating cytotoxicity in hypoxicischemic brain damage (McDonald and Johnston, 1990; Johnston, 2001; Johnston et al., 2001 ). Our previous studies showed that NMDA receptor density was higher in young girls with RTT (Blue et al., 1999) . Our hypothesis was that enhanced excitatory neurotransmission during the early course of RTT and in the encephalopathic phase could worsen the disorder by impairing cortical plasticity, synaptogenesis and pruning, and behavior (Lappalainen et al., 1996; Blue et al., 1999; Mullaney et al., 2004) . Thus, the higher degree of cell death observed in MeCP2 null and heterozygous cells is possibly the result of enhanced excitotoxicity triggered by NMDA subtype of glutamate receptors and hypoxia.
The importance of MeCP2 in neuronal function is also evident from our findings that reintroduction of the intact MeCP2 gene into MeCP2Ϫ/Ϫ cells significantly reduced their vulnerability to hypoxia. The direct involvement of MeCP2 is further supported by MeCP2 loss-of-function experiments. MeCP2 gene silencing using MeCP2 siRNA in WT CGCs significantly increased the number of TUNEL (ϩ) cells comparable to that observed in MeCP2Ϫ/Ϫ cells. These results suggest a correlation between MeCP2 function and the cell viability after exposure to hypoxia. The specific importance of functional MeCP2 role in neuropathology is also evident from our neurotrophic factor FGF-1 pretreatment findings. Under conditions that we previously found to provide almost complete neuroprotection (Hossain et al., 2002; Russell et al., 2006 ) the FGF-1 pretreatment only partially attenuated hypoxia-induced neuronal death in MeCP2Ϫ/Ϫ cells compared with WT control cells. Taken together, these results suggest a direct role for MeCP2 function in neuronal injury and death triggered by enhanced excitatory neurotransmission (Lappalainen et al., 1996; Blue et al., 1999; Nelson et al., 2006) .
Caspase dependent and independent mechanisms for cell death
Many human disorders affecting the brain are due to mitochondrial dysfunction (Dotti et al., 1993; Armstrong, 2005) , sometimes resulting in increased oxidative stress or induction of neuronal apoptosis (Penninger and Kroemer, 2003) . More recently, mitochondrial dysfunction due to physiological changes has been shown to contribute to the pathology in the MeCP2-null mouse (Kriaucionis et al., 2006) . Activation of the caspase cascade and AIF release are mitochondria-mediated events that lead to apoptotic cell death under various cytotoxic insults (Susin et al., 1999; Penninger and Kroemer, 2003) . Mitochondrial membrane permeablization leads to caspase activation (Kroemer and Reed, 2000) and release of AIF from mitochondria into cytoplasm and nucleus (Susin et al., 1999; Cande et al., 2004) . MeCP2Ϫ/Ϫ cells showed increased activation of caspase-3 under hypoxic conditions. This caspasedependent apoptotic (programmed cell death) mechanism is more active in the cerebellum at this time point due to its prolonged period of development (Naidu et al., 2003; Mullaney et al., 2004) . AIF is a key player in caspase-independent apoptosis, which after its release from mitochondria translocates to nucleus in response to specific death signals and causes high molecular weight DNA fragmentation and cell death (Susin et al., 1999; Daugas et al., 2000; Yu et al., 2003; Cheung et al., 2005) . We found that AIF release was increased in MeCP2Ϫ/Ϫ cells after hypoxia. The caspase inhibitor ZVAD-FMK had little or no effect on the AIF release and its nuclear translocation, suggesting that the AIF-mediated contribution to cell death was caspase-independent (Susin et al., 1999; Cande et al., 2004) . Taken together these results indicate that both caspase-dependent and caspase-independent AIF-mediated mechanisms contribute to cell death under excitotoxic and hypoxic conditions.
CONCLUSION
In summary, the loss of MeCP2 function or complete knockdown of MeCP2 induces a death program at an earlier time period than in WT mice after hypoxia and excitotoxicity in cerebellar granule neurons. The neuronal death was significantly greater in CGCs lacking functional MeCP2 protein expression compared with WTs, and occurred via both caspase-and AIF-dependent manner. In view of the fact that MeCP2 inactivation derepresses gene expression or transcriptional dysregulation (Chen et al., 2003) , it is possible that overexpression of prodeath component molecules or their enhanced levels of activation in central neurons makes neurons more vulnerable to injury and death. Our findings clearly suggest a novel, yet unknown, role for MeCP2 in the CNS in the control of neuronal response to cell death.
